Osteoporosis Clinical Trial
Official title:
Controlled Trial to Increase Detection and Treatment of Osteoporosis in Older Patients With a Wrist Fracture
The primary objective of this proposed research is to improve the quality of care for
patients who present to the Emergency Department with osteoporosis and a fracture of the
wrist, by increasing the use of proven efficacious osteoporosis treatment. This is the
primary study outcome, and it is defined as starting any one of hormone therapy, a
bisphosphonate, raloxifene, or calcitonin within 6 months of a fracture of the wrist.
The study hypothesis is that a quality improvement intervention (with multiple components
that include a notification system for primary care physicians, patient-specific reminders,
locally generated treatment guidelines endorsed by opinion leaders, and patient education
and counseling) will lead to increased use of proven efficacious osteoporosis treatments in
patients eligible for secondary prevention. This hypothesis will be tested by comparing the
intervention with usual care controls, in a prospective nonrandomized controlled trial.
BACKGROUND: Osteoporosis is a progressive condition that causes a loss of bone mass,
skeletal fragility, and fractures. Fractures result in pain, disability, deformity, and
death. Osteoporosis is a major population health problem affecting 1.4 million Canadians,
25% of women and 12% of men over the age of 50 years. Current guidelines recommend
aggressive secondary prevention in patients with osteoporosis who have suffered a fracture,
because these patients have as high as a 20% risk of fracture in the following year, and
because there are now proven efficacious treatments that can reduce this risk by 40-60%.
Nevertheless, recent studies have shown that these patients are under-recognized and
under-treated, demonstrating a care gap between evidence-based best practice and usual care.
All patients with osteoporotic fractures (i.e., of the hip, vertebrae, or wrist) benefit
from treatment. However, patients who present with a wrist fracture may be best suited to an
intervention to improve secondary prevention practices, because wrist fractures are
“sentinel events” in the natural history of osteoporosis: they are common, easily diagnosed,
always present to medical attention, and occur years before the more devastating and costly
fractures of the hip and vertebrae.
OBJECTIVES: The primary objective of this study is to improve the quality of care for
patients who present to the ED with osteoporosis and a fracture of the wrist, by increasing
the use of proven efficacious osteoporosis treatment. This is the primary study outcome, and
it is defined as starting any one of hormone replacement therapy, a bisphosphonate,
raloxifene, or calcitonin within 6 months of a fracture of the wrist.
HYPOTHESIS: A quality improvement intervention directed at patients and their primary care
physicians will increase the use of proven efficacious osteoporosis treatment. The
intervention itself has multiple components that include: a notification system and
patient-specific reminders for primary care physicians, locally developed treatment
guidelines endorsed by opinion leaders, and patient education and counseling. The study
hypothesis will be tested by comparing the intervention to usual care controls, in a
prospective nonrandomized controlled trial.
SPECIFIC AIMS: To determine whether the proposed intervention can-
- 1. Increase the use of proven efficacious osteoporosis treatment in patients with a
fracture of the wrist,
- 2. Increase appropriate use of bone mineral density testing,
- 3. Increase patients’ knowledge of osteoporosis and satisfaction.
;
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06287502 -
Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis
|
N/A | |
Completed |
NCT03822078 -
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women
|
Phase 1 | |
Recruiting |
NCT05845021 -
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
|
N/A | |
Completed |
NCT00092066 -
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
|
Phase 3 | |
Recruiting |
NCT04754711 -
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
|
N/A | |
Completed |
NCT04736693 -
Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
|
||
Not yet recruiting |
NCT06431867 -
Primary Care Management of Osteoporosis in Older Women
|
||
Completed |
NCT02922478 -
Role of Comorbidities in Chronic Heart Failure Study
|
||
Recruiting |
NCT02616627 -
Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
|
||
Recruiting |
NCT02635022 -
Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
|
||
Active, not recruiting |
NCT02617303 -
Prevention of Falls and Its Consequences in Elderly People
|
N/A | |
Completed |
NCT02566655 -
Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis
|
Phase 1 | |
Completed |
NCT02559648 -
Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis
|
Phase 2 | |
Completed |
NCT03420716 -
Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women
|
N/A | |
Not yet recruiting |
NCT02223572 -
Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture
|
N/A | |
Not yet recruiting |
NCT01854086 -
Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
|
N/A | |
Unknown status |
NCT01913834 -
Nasally and sc Administered Teriparatide in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02003716 -
DeFRA Questionnaire as an Anamnestic Form
|
N/A | |
Completed |
NCT01694784 -
Understanding and Discouraging Overuse of Potentially Harmful Screening Tests
|
N/A | |
Completed |
NCT01401556 -
C-STOP Fracture Trial
|
N/A |